Mineralocorticoid receptor (MR) antagonists are well established in the treatment of chronic left heart disease, however, there is an ever growing body of evidence suggesting potential benefits in other cardiovascular disease. Here, we evaluated the effects of MR antagonists on more…
Mineralocorticoid receptors control extracellular matrix composition in the left ventricle and also extracardiac tissues. In the present issue of Circulation Research, the group of Natalia Lopez further extend this view, demonstrating that the aldosterone/MR signaling pathway drives mitral valve remodeling more…
The newly established German Collaborative Research Centre (SFB1425) “Heterocellular Nature of Cardiac Lesions: Identities, Interactions, Implications” is recruiting 13 PhD students and 5 post-docs to join cutting-edge research that aims to develop insight and tools to improve clinical outcomes after more…
